Completed
Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
NCT00030966
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- University of Alabama-Birmingham, Department of Neurology Birmingham, Alabama, United States
- Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States
- University of Arkansas For Medical Sciences Little Rock, Arkansas, United States
- University of California - Irvine Irvine, California, United States